Skip to main content

GOLDMAN SACHS GROUP INC

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in FULC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,005,595
-$380,946 QoQ
Shares Held
1,094,425
+91.4% QoQ
Ownership
1.43%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 154 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,376,870 across 359 Biotechnology names. FULC ranks #203 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,005,595 1,094,425
2026-03-31 $4,386,541 571,909
2025-12-31 $3,663,070 323,879
2025-09-30 $5,394,429 586,351
2025-06-30 $7,867,526 1,143,536
2024-12-31 $2,548,611 542,258
2024-09-30 $3,312,820 927,961
2024-06-30 $3,475,050 560,492
2024-03-31 $7,648,948 810,270
2022-03-31 $5,620,232 237,642
2021-06-30 $287,843 27,466
2021-03-31 $169,243 14,367
2020-12-31 $173,975 14,857